Lactose (India) Ltd
Incorporated in 1991, Lactose (India) Ltd manufactures Pharmaceutical Products and carries out job work[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit |
Ratios
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Electricity Consumption KWH ・Standalone data |
|
||||||||||
| Foreign Exchange Earned (Export Revenue) Rs Lakh ・Standalone data |
|||||||||||
| Installed Capacity - Lactose Powder MTPA ・Standalone data |
|||||||||||
| Bio Coal Consumption MT ・Standalone data |
|||||||||||
| Employee Count count ・Standalone data |
|||||||||||
| Installed Capacity - Lactulose MTPA ・Standalone data |
|||||||||||
| Number of Registered Customers count ・Standalone data |
|||||||||||
| Order Book (Quarterly) Rs Crore ・Standalone data |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On Wednesday, October 21, 2026 For Fixation Of Record Date
- Board fixed November 2, 2026 record date for Vitanosh amalgamation; 0.7946 LIL shares per VIPL share.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Submitted Regulation 74(5) certificate for dematerialization details for quarter ended 30 September 2026.
-
Disclosure Of Voting Results Of The Of 35Th Annual General Meeting Of Lactose India Limited (''Company'') Held On 30Th September, 2026
- 35th AGM voting results disclosed; all resolutions approved on 30 September 2026.
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
-
Announcement under Regulation 30 (LODR)-Change in Management
- Alpesh A. Lakeshri appointed cost auditor for FY 2026-27 on 30 September 2026.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Business Overview:[1][2]
LIL, associated with the Kerry Group, is involved in the production of pharmaceuticals, drugs, medicines, chemicals, and food products. The company operates as a manufacturer, processor, exporter, importer, and distributor across multiple categories, including:
a) all types of food—finished, semi-finished, processed, and unprocessed;
b) dairy products such as milk cream, ice cream, curd, paneer, cheese, and sweets;
c) pharmaceuticals, bulk drugs, and medicines; and
d) chemicals, compounds, derivatives, and intermediates.